Abstract
Purpose
Methods
Results
Conclusions
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of MedicineReferences
- Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs.Cochrane Database Syst Rev. 2017; 6CD009761
- Normobaric hypoxia and symptoms of acute mountain sickness: elevated brain volume and intracranial hypertension.Ann Neurol. 2014; 75: 890-898
- The cerebral venous system and hypoxia.J Appl Physiol (1985). 2016; 120: 244-250
- Upright patient positioning in the management of intracranial hypertension.Surg Neurol. 1981; 15: 148-152
Küpper T, Gieseler U, Angelini C, Hillebrandt D, Milledge J. Recommendation of the UIAA Medical Commission Vol 2: emergency field management of acute mountain sickness, high altitude pulmonary edema, and high altitude cerebral edema. Available at: www.theuiaa.org/medical_advice.html (2012). Accessed Febraury 22nd 2020.
- Cluster-randomized, crossover trial of head positioning in acute stroke.N Engl J Med. 2017; 376: 2437-2447
- Drug use and misuse in the mountains: a UIAA MedCom consensus guide for medical professionals.High Alt Med Biol. 2016; 17: 157-184
- Interventions for treating acute high altitude illness.Cochrane Database Syst Rev. 2018; 6CD009567
Article info
Publication history
Footnotes
Trial registration: German Clinical Trial Register DRKS00012676.
Funding: This study was supported by the programmatic funding of the German Aerospace Center (DLR) and by a grant from the German Society for Mountain- and Expedition Medicine (BExMed).
Conflict of Interest: UL reports grants from the German Society for Mountain and Expedition Medicine (BExMed) during the conduct of the study. All other authors have nothing to disclose. UL affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.
Authorship: UL: Conceptualization, methodology, formal analysis, investigation, writing - original draft, review & editing, funding acquisition; VF: Formal analysis, investigation, writing - review and editing, project administration; JT: Investigation, project administration, provision of study materials; E-ME: Methodology, supervision, writing - review and editing; GS: Methodology, writing - review and editing, supervision; Y-YMH: Investigation, project administration; PG: Provision and design of study materials (wedges), visualization, investigation; PM: Formal analysis, methodology; programming; JJ: Supervision, writing - review and editing, funding acquisition, methodology.
The authors declare that the data supporting the findings of this study are available within the article. Anonymized data will be shared from the corresponding author upon reasonable request from any qualified investigator.
